Malignant Endometrial Neoplasm — Trials

Malignant Endometrial Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,198 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 359
Recruiting: 204
Ph III recruiting: 21
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (112)

clinicaltrialsPublishedShowing 151–200 of 270 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06751589	A Study of a Weight Loss Intervention in People With Endometrial Cancer	recruiting	Early Phase 1	36	Memorial Sloan Kettering Cancer CenterOTHER	1	Apr 13, 2026	clinicaltrials
NCT07062016	Molecular and ctDNA Characterization of High-Risk Endometrial Cancer	recruiting	—	100	Mayo ClinicOTHER	1	Apr 13, 2026	clinicaltrials